Abbott Laboratories (ABT)
After hours:
- Motley Fool
Is Abbott Laboratories a Good Dividend Stock to Buy Now?
It's that time of year when Wall Street analysts start adjusting their predictions, and one dividend-paying stock, in particular, is getting a lot of positive attention. Abbott Laboratories (NYSE: ABT) reported fourth-quarter earnings on Thursday, Jan. 26. Since then, Sanford C. Bernstein, Raymond James, Stifel Nicolaus, and Barclays have all raised their price targets on the healthcare conglomerate.
- Simply Wall St.
Abbott Laboratories Full Year 2022 Earnings: EPS Beats Expectations
Abbott Laboratories ( NYSE:ABT ) Full Year 2022 Results Key Financial Results Revenue: US$43.7b (up 1.3% from FY 2021...
- Zacks
Abbott (ABT) Reports Q4 Earnings: What Key Metrics Have to Say
While the top- and bottom-line numbers for Abbott (ABT) give a sense of how the business performed in the quarter ended December 2022, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
